Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 6/2019

01-06-2019 | Peritonsillar Abscess | Laryngology

Peritonsillar abscess is frequently accompanied by sepsis symptoms

Authors: Risto Vaikjärv, Reet Mändar, Priit Kasenõmm

Published in: European Archives of Oto-Rhino-Laryngology | Issue 6/2019

Login to get access

Abstract

Purpose

To evaluate how many patients with peritonsillar abscess (PTA) fulfill sepsis criteria and if there is any difference in risk factors and treatment results between patients with and without sepsis symptoms. We also aimed to evaluate the utility of several clinical and laboratory markers for diagnosing PTA.

Methods

Study group consisted of 92 patients with PTA undergoing bilateral emergency tonsillectomy. Blood samples, pus samples and clinical data were collected. Patients were evaluated for sepsis criteria based on 2001 International Sepsis Definitions Conference.

Results

Sepsis diagnostic criteria were fulfilled in half of patients (51.1%). Smokers (p = 0.016) and patients who had not received antibiotic treatment (p = 0.003) had more sepsis symptoms. Procalcitonin levels were moderate and there was no difference between the groups. In majority of the patients, the pus samples contained undetectable or mild levels of amylase while 12 patients had pus amylase at least twice higher than in blood serum and among them, the levels were remarkably high in 9 patients.

Conclusion

Half of the patients with PTA meet the diagnostic criteria for sepsis. The risk factors for the latter include current smoking and not receiving antibiotic treatment before hospitalization. PTA treatment outcome does not differ between the patients with and without sepsis clinical picture in case of surgical treatment. C-reactive protein appears to be better diagnostic marker for PTA than procalcitonin. A portion of the PTA patients have remarkably high amylase level in the pus indicating possible association with Weber’s salivary glands infection.
Literature
1.
go back to reference Mitchelmore IJ, Prior AJ, Montgomery PQ, Tabaqchali S (1995) Microbiological features and pathogenesis of peritonsillar abscesses. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 14:870–877CrossRef Mitchelmore IJ, Prior AJ, Montgomery PQ, Tabaqchali S (1995) Microbiological features and pathogenesis of peritonsillar abscesses. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 14:870–877CrossRef
2.
go back to reference Passy V (1994) Pathogenesis of peritonsillar abscess. Laryngoscope 104:185–190PubMed Passy V (1994) Pathogenesis of peritonsillar abscess. Laryngoscope 104:185–190PubMed
3.
go back to reference Herzon FS, Mosher Harris P (1995) Award thesis. Peritonsillar abscess: incidence, current management practices, and a proposal for treatment guidelines. Laryngoscope 105:1–17CrossRefPubMed Herzon FS, Mosher Harris P (1995) Award thesis. Peritonsillar abscess: incidence, current management practices, and a proposal for treatment guidelines. Laryngoscope 105:1–17CrossRefPubMed
4.
5.
go back to reference Klug TE (2017) Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess. Dan Med J 64(3):B5333PubMed Klug TE (2017) Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess. Dan Med J 64(3):B5333PubMed
6.
go back to reference Chang BA, Thamboo A, Burton MJ, Diamond C, Nunez DA (2016) Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess. Cochrane Database Syst Rev 12:CD006287PubMed Chang BA, Thamboo A, Burton MJ, Diamond C, Nunez DA (2016) Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess. Cochrane Database Syst Rev 12:CD006287PubMed
7.
go back to reference Levy MM et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250–1256CrossRefPubMed Levy MM et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250–1256CrossRefPubMed
8.
go back to reference Klug TE, Rusan M, Clemmensen KKB, Fuursted K, Ovesen T (2013) Smoking promotes peritonsillar abscess. Eur Arch Otorhinolaryngol 270:3163–3167CrossRefPubMed Klug TE, Rusan M, Clemmensen KKB, Fuursted K, Ovesen T (2013) Smoking promotes peritonsillar abscess. Eur Arch Otorhinolaryngol 270:3163–3167CrossRefPubMed
9.
go back to reference Lepelletier D et al (2017) Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study. Eur J Clin Microbiol Infect Dis 36:57–63CrossRefPubMed Lepelletier D et al (2017) Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study. Eur J Clin Microbiol Infect Dis 36:57–63CrossRefPubMed
11.
go back to reference Brook I, Gober AE (2005) Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers. Chest 127:2072–2075CrossRefPubMed Brook I, Gober AE (2005) Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers. Chest 127:2072–2075CrossRefPubMed
13.
go back to reference Vaikjärv R et al (2016) Microbiology of peritonsillar abscess in the South Estonian population. Microb Ecol Health Dis 27:27787PubMed Vaikjärv R et al (2016) Microbiology of peritonsillar abscess in the South Estonian population. Microb Ecol Health Dis 27:27787PubMed
14.
go back to reference Powell EL, Powell J, Samuel JR, Wilson JA (2013) A review of the pathogenesis of adult peritonsillar abscess: time for a re-evaluation. J Antimicrob Chemother 68:1941–1950CrossRefPubMed Powell EL, Powell J, Samuel JR, Wilson JA (2013) A review of the pathogenesis of adult peritonsillar abscess: time for a re-evaluation. J Antimicrob Chemother 68:1941–1950CrossRefPubMed
15.
go back to reference Jin M, Khan AI (2010) Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med 41:173–177CrossRef Jin M, Khan AI (2010) Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med 41:173–177CrossRef
16.
go back to reference El-Saied S et al (2014) A comparison between amylase levels from peritonsillar, dental and neck abscesses. Clin Otolaryngol 39:359–361CrossRefPubMed El-Saied S et al (2014) A comparison between amylase levels from peritonsillar, dental and neck abscesses. Clin Otolaryngol 39:359–361CrossRefPubMed
17.
go back to reference Knipping S, Löwe S, Lautenschläger C, Schrom T (2009) Is postoperative antibiotic treatment mandatory after abscess tonsillectomy. HNO 57:230–238CrossRefPubMed Knipping S, Löwe S, Lautenschläger C, Schrom T (2009) Is postoperative antibiotic treatment mandatory after abscess tonsillectomy. HNO 57:230–238CrossRefPubMed
18.
go back to reference Battaglia A et al (2018) Comparison of medical therapy alone to medical therapy with surgical treatment of peritonsillar abscess. Otolaryngol Head Neck Surg 158:280–286CrossRefPubMed Battaglia A et al (2018) Comparison of medical therapy alone to medical therapy with surgical treatment of peritonsillar abscess. Otolaryngol Head Neck Surg 158:280–286CrossRefPubMed
Metadata
Title
Peritonsillar abscess is frequently accompanied by sepsis symptoms
Authors
Risto Vaikjärv
Reet Mändar
Priit Kasenõmm
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 6/2019
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05424-6

Other articles of this Issue 6/2019

European Archives of Oto-Rhino-Laryngology 6/2019 Go to the issue